Patterns and Predictors of Low-Calorie Sweetener Consumption during Pregnancy: Findings from a National Survey
Nutrients · 28.09.2023 · 15 (19) · 4196
DOI: 10.3390/nu15194196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 28.09.2023. Verfasst von Bereket Gebremichael und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutrition, School of Agriculture, Food and Wine, The University of Adelaide, Glen Osmond, Adelaide, SA 5064, Australia. Hauptthemen laut MEDLINE: Sweetening Agents, Sugar-Sweetened Beverages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Adelaide research scholarship.
Abstract (Originalsprache)
Recently, the World Health Organization recommended avoiding low-calorie sweeteners (LCS) during pregnancy due to concerns that it may be linked to adverse pregnancy outcomes and offspring wellbeing. This study examined the patterns and predictors of LCS consumption among pregnant women in Australia. A survey was conducted among 422 pregnant women aged 18–50 years. Sociodemographic, lifestyle, dietary intake including LCS consumption, pregnancy-related characteristics, and awareness about the health effects of LCS were assessed. We used latent class analysis and multinomial logistic regression to identify LCS consumption patterns and predictors of consumption patterns, respectively. The mean (SD) age of the women was 30 (4.6) years. Three LCS consumption patterns were identified: infrequent or non-consumers representing 50% of the women, moderate consumers encompassing 40% of the women, and the remaining were habitual consumers. Over two-thirds (71%) of women were not aware of the potential adverse effects of LCS, and only a quarter of them were concerned about the possible adverse effects on their health and their offspring. Increasing age and living with a medical condition decreased the likelihood of moderate consumption by 7% and 55%, respectively. Frequent sugar-sweetened beverage consumption and gestational diabetes predicted habitual LCS consumption. This research suggested widespread LCS consumption among pregnant women in Australia, but lower awareness of its potential adverse health effects. Interventions to increase awareness of potential adverse effects are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food and Nutrition, School of Agriculture, Food and Wine, The University of Adelaide, Glen Osmond, Adelaide, SA 5064, Australia.
- Robinson Research Institute, The University of Adelaide, Adelaide, SA 5006, Australia.
- College of Health Science, Addis Ababa University, Addis Ababa AA 1000, Ethiopia.
- School of Public Health, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA 5000, Australia.
- Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia.
- College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia.
ORCID-Profile: Bereket Gebremichael, Mumtaz Begum
Förderung
- University of Adelaide research scholarship
Zitieren
APA
Gebremichael, B., Lassi, Z. S., Begum, M., Mittinty, M., & Zhou, S. J. (2023). Patterns and Predictors of Low-Calorie Sweetener Consumption during Pregnancy: Findings from a National Survey. Nutrients, 15(19), 4196. https://doi.org/10.3390/nu15194196
Vancouver
Gebremichael B, Lassi ZS, Begum M, Mittinty M, Zhou SJ. Patterns and Predictors of Low-Calorie Sweetener Consumption during Pregnancy: Findings from a National Survey. Nutrients. 2023;15(19):4196. doi:10.3390/nu15194196
BibTeX
@article{Gebremichael2023,
author = {Gebremichael, Bereket and Lassi, Zohra S and Begum, Mumtaz and Mittinty, Murthy and Zhou, Shao-Jia},
title = {Patterns and Predictors of Low-Calorie Sweetener Consumption during Pregnancy: Findings from a National Survey},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {19},
pages = {4196},
doi = {10.3390/nu15194196}
}
EUVIMED